Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

During the Trading Day
17.66 +0.36 / +2.08%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
17.99 +0.33 / +1.87%
Volume: 19.7K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues803.0K1.5M12.0M122.0M
Cost of Goods Sold29.7M--362.0K4.8M
Depreciation And Amortization879.0K871.0K742.0K928.0K
Operating ExpensesGross Income-29.8M--10.9M116.3M
General Expenses7.9M42.8M72.8M92.1M
Research And Development--23.5M17.2M19.6M
Total Operating Expenses38.6M43.6M73.9M97.8M
Non-Operating ExpensesOperating Income-37.8M-42.2M-61.9M24.2M
Extraordinary Credit0.
Extraordinary Charge0.000.00-22.9M-2.6M
Interest Expense On Debt1.9M3.6M7.8M5.0M
Other Expenses117.0K-660.0K101.0K39.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-39.5M-46.3M-92.3M19.9M
Income Taxes-16.2M0.000.000.00
Preferred Dividend-3.4M-1.1M0.000.00
Discontinued Operations2.2M0.000.000.00
Extraordinary Items74.9M0.000.000.00
Net Income-21.0M-46.3M-92.3M19.9M
Shares To Calculate EPSShares To Calculate EPS23.9M17.4M31.8M42.3M
Shares To Calculate EPS Diluted23.9M17.4M31.8M50.6M
Earnings Per ShareEPS$31.39-$2.72-$2.90$0.32
EPS Diluted-$1.02-$2.72-$2.90$0.32

To view my watchlist

Not a member yet?

Sign up now for a free account